by Rosalyn Carson-DeWitt, MD
Alzheimer's disease is a condition that destroys brain cells. People with this disease slowly lose the ability to learn, function, and remember. It is the most common cause of dementia. Dementia is a loss in mental abilities that is great enough to interfere with daily life.
The cause of Alzheimer's is not yet known. Two factors that may play a role in the development of Alzheimer's disease are:
Risk Factors TOP
People who are over 65 years of age have an increased risk of Alzheimer's disease.
Other factors that may increase your chance of Alzheimer's disease include:
Researchers are studying the following to see if they are related to Alzheimer's disease:
The disease begins as mild memory lapses. It will continue toward a profound loss of memory and function. Alzheimer's disease is divided into 3 stages:
There are no tests to confirm Alzheimer's. You will be asked about your symptoms and medical history. A physical exam will be done. Neurological, psychological, and mental status exams may be done.
Your bodily fluids may be tested. This can be done with:
Images may be taken of your bodily structures. This can be done with:
Your brain's electrical activity may be measured. This can be done with electroencephalogram (EEG).
There is no cure for Alzheimer's disease. There are no certain ways to slow its progression. Medication is available to treat some of the symptoms. The goal is to find a medication that can manage the symptoms or slow the condition's course.
Medications for Symptoms and Disease Progression
Medications that have been approved to reduce the symptoms of Alzheimer's disease include:
Managing the disease includes:
Psychiatric Medication TOP
Psychiatric symptoms may occur with Alzheimer’s disease. Your doctor may prescribe medication to treat:
There are no guidelines for preventing Alzheimer's disease because the exact cause is unknown. However, the following factors may help you reduce your risk of Alzheimer's disease:
National Institute on Aging
Alzheimer Society Canada
Albanese E, Dangour AD, Uauy R, et al. Dietary fish and meat intake and dementia in Latin America, China, and India: A 10/66 Dementia Research Group population-based study. Am J Clin Nutr. 2009;90(2):392-400.
Alzheimer dementia. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T114193/Alzheimer-dementia. Updated August 27, 2016. Accessed September 30, 2016.
Alzheimer's disease medications fact sheet. National Institute on Aging website. Available at:
...(Click grey area to select URL)
Accessed August 18, 2014.
Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: Meta-analysis of prospective studies. Am J Geriatr Psychiatry. 2009;17(7):542-555.
Carillo MC, Blackwell A, Hampel H, et al. Early risk assessment for Alzheimer's disease. Alzheimers Dement. 2009;5(2):182-196.
Deweerdt S. Prevention: Activity is the best medicine. Nature. 2011;475(7355):S16-S17.
Gidoni R, Benussi L, Paterlini A, Albertini V, Binetti G, Emanuele E. Cerebrospinal fluid biomarkers in Alzheimer’s disease: The present and the future. Neurodegen Dis. 2011;8(6):413-420.
Green RC, Cupples LA, Go R, et al. Risk of dementia among white and African-American relatives of patients with Alzheimer disease. JAMA. 2002;287(3):329-336.
Hampel H, Frank R, Broich K, et al. Biomarkers for Alzheimer’s disease: Academic, industry, and regulatory perspectives. Nat Rev Drug Discov. 2010;9(7):560-574.
Hayden KM, Welsh-Bohmer KA. Epidemiology of cognitive aging and Alzheimer’s disease: Contributions of the Cache County Utah study of memory, health, and aging. Curr Top Behav Neurosci. 2012;10:3-31.
Neugroschl J, Sano M. An update on treatment and prevention strategies for Alzheimer’s disease. Curr Neurol Neurosci Rep. 2009;9(5):368-376.
Ruitenberg A, van Swieten JC, Wittemen JC, et al. Alcohol consumption and risk of dementia: The Rotterdam Study. Lancet. 2002;359(9303):281-286.
1/8/2010 DynaMed Plus Systematic Literature Surveillance. Available at: http://www.dynamed.com/topics/dmp~AN~T114193/Alzheimer-dementia: Snitz BE, O'Meara ES, et al. Ginkgo biloba for preventing cognitive decline in older adults: A randomized trial. JAMA. 2009;302(24):2663-2670.
5/4/2012 DynaMed Plus Systematic Literature Surveillance. Available at: http://www.dynamed.com/topics/dmp~AN~T114193/Alzheimer-dementia: Buchman AS, Boyle PA, et al. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 2012;78(17):1323-1329.
9/3/2014 DynaMed Plus Systematic Literature Surveillance. Available at: http://www.dynamed.com/topics/dmp~AN~T114193/Alzheimer-dementia: Wippold FJ, Brown DC, Broderick DF, et al. American College of Radiology (ACR) Appropriateness Criteria for dementia and movement disorders. Available at:
...(Click grey area to select URL)
Updated 2014. Accessed September 3, 2014.
10/17/2016 DynaMed Plus Systematic Literature Surveillance. Available at: http://www.dynamed.com/topics/dmp~AN~T114193/Alzheimer-dementia: Arvanitakis Z, Capuano AW, et al. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 Aug;15(9):934-943. .
Last reviewed August 2015 by Rimas Lukas, MD